Intact p53-Dependent Responses in miR-34–Deficient Mice
MicroRNAs belonging to the miR-34 family have been proposed as critical modulators of the p53 pathway and potential tumor suppressors in human cancers. To formally test these hypotheses, we have generated mice carrying targeted deletion of all three members of this microRNA family. We show that complete inactivation of miR-34 function is compatible with normal development in mice. Surprisingly, p53 function appears to be intact in miR-34–deficient cells and tissues. Although loss of miR-34 expression leads to a slight increase in cellular proliferation in vitro, it does not impair p53-induced cell cycle arrest or apoptosis. Furthermore, in contrast to p53-deficient mice, miR-34–deficient animals do not display increased susceptibility to spontaneous, irradiation-induced, or c-Myc–initiated tumorigenesis. We also show that expression of members of the miR-34 family is particularly high in the testes, lungs, and brains of mice and that it is largely p53-independent in these tissues. These findings indicate that miR-34 plays a redundant function in the p53 pathway and suggest additional p53-independent functions for this family of miRNAs.
Vyšlo v časopise:
Intact p53-Dependent Responses in miR-34–Deficient Mice. PLoS Genet 8(7): e32767. doi:10.1371/journal.pgen.1002797
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pgen.1002797
Souhrn
MicroRNAs belonging to the miR-34 family have been proposed as critical modulators of the p53 pathway and potential tumor suppressors in human cancers. To formally test these hypotheses, we have generated mice carrying targeted deletion of all three members of this microRNA family. We show that complete inactivation of miR-34 function is compatible with normal development in mice. Surprisingly, p53 function appears to be intact in miR-34–deficient cells and tissues. Although loss of miR-34 expression leads to a slight increase in cellular proliferation in vitro, it does not impair p53-induced cell cycle arrest or apoptosis. Furthermore, in contrast to p53-deficient mice, miR-34–deficient animals do not display increased susceptibility to spontaneous, irradiation-induced, or c-Myc–initiated tumorigenesis. We also show that expression of members of the miR-34 family is particularly high in the testes, lungs, and brains of mice and that it is largely p53-independent in these tissues. These findings indicate that miR-34 plays a redundant function in the p53 pathway and suggest additional p53-independent functions for this family of miRNAs.
Zdroje
1. VogelsteinBLaneDLevineAJ 2000 Surfing the p53 network. Nature 408 307 310
2. ZilfouJTLoweSW 2009 Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol 1 a001883
3. SpeidelD 2010 Transcription-independent p53 apoptosis: an alternative route to death. Trends Cell Biol 20 14 24
4. WeiCLWuQVegaVBChiuKPNgP 2006 A global map of p53 transcription-factor binding sites in the human genome. Cell 124 207 219
5. OdaEOhkiRMurasawaHNemotoJShibueT 2000 Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288 1053 1058
6. JeffersJRParganasELeeYYangCWangJ 2003 Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 4 321 328
7. BrugarolasJChandrasekaranCGordonJIBeachDJacksT 1995 Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377 552 557
8. DengCZhangPHarperJWElledgeSJLederP 1995 Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82 675 684
9. BrownJPWeiWSedivyJM 1997 Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277 831 834
10. MiyashitaTReedJC 1995 Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80 293 299
11. NakanoKVousdenKH 2001 PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7 683 694
12. HollsteinMSidranskyDVogelsteinBHarrisCC 1991 p53 mutations in human cancers. Science 253 49 53
13. BommerGTGerinIFengYKaczorowskiAJKuickR 2007 p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17 1298 1307
14. ChangTCWentzelEAKentOARamachandranKMullendoreM 2007 Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26 745 752
15. ColeKAAttiyehEFMosseYPLaquagliaMJDiskinSJ 2008 A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 6 735 742
16. CorneyDCFlesken-NikitinAGodwinAKWangWNikitinAY 2007 MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67 8433 8438
17. HeLHeXLimLPde StanchinaEXuanZ 2007 A microRNA component of the p53 tumour suppressor network. Nature 447 1130 1134
18. Raver-ShapiraNMarcianoEMeiriESpectorYRosenfeldN 2007 Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26 731 743
19. TarasovVJungPVerdoodtBLodyginDEpanchintsevA 2007 Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6 1586 1593
20. TazawaHTsuchiyaNIzumiyaMNakagamaH 2007 Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci U S A 104 15472 15477
21. WelchCChenYStallingsRL 2007 MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26 5017 5022
22. HagmanZLarneOEdsjoABjartellAEhrnstromRA 2010 miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions. Int J Cancer
23. YamakuchiMFerlitoMLowensteinCJ 2008 miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci U S A 105 13421 13426
24. KatoMParanjapeTMullerRUNallurSGillespieE 2009 The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells. Oncogene 28 2419 2424
25. CannellIGKongYWJohnstonSJChenMLCollinsHM 2010 p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication. Proceedings of the National Academy of Sciences of the United States of America 107 5375 5380
26. LuJGetzGMiskaEAAlvarez-SaavedraELambJ 2005 MicroRNA expression profiles classify human cancers. Nature 435 834 838
27. GallardoENavarroAVinolasNMarradesRMDiazT 2009 miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis 30 1903 1909
28. LodyginDTarasovVEpanchintsevABerkingCKnyazevaT 2008 Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer. Cell Cycle 7 2591 2600
29. CorneyDCHwangCIMatosoAVogtMFlesken-NikitinA 2010 Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res 16 1119 1128
30. ChoiYJLinCPHoJJHeXOkadaN 2011 miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 13 1353 1360
31. SerranoMLinAWMcCurrachMEBeachDLoweSW 1997 Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88 593 602
32. CarrAM 2000 Cell cycle. Piecing together the p53 puzzle. Science 287 1765 1766
33. SherrCJWeberJD 2000 The ARF/p53 pathway. Curr Opin Genet Dev 10 94 99
34. LoweSWLinAW 2000 Apoptosis in cancer. Carcinogenesis 21 485 495
35. HarveyMSandsATWeissRSHegiMEWisemanRW 1993 In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8 2457 2467
36. HanahanDWeinbergRA 2000 The hallmarks of cancer. Cell 100 57 70
37. AttardiLDde VriesAJacksT 2004 Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer. Oncogene 23 973 980
38. LalAThomasMPAltschulerGNavarroFO'DayE 2011 Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet 7 e1002363 doi:10.1371/journal.pgen.1002363
39. LoweSWSchmittEMSmithSWOsborneBAJacksT 1993 p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362 847 849
40. LoweSWJacksTHousmanDERuleyHE 1994 Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells. Proc Natl Acad Sci U S A 91 2026 2030
41. SherrCJ 2001 The INK4a/ARF network in tumour suppression. Nat Rev Mol Cell Biol 2 731 737
42. WhytePBuchkovichKJHorowitzJMFriendSHRaybuckM 1988 Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334 124 129
43. DonehowerLAHarveyMSlagleBLMcArthurMJMontgomeryCAJr 1992 Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 215 221
44. JacksTRemingtonLWilliamsBOSchmittEMHalachmiS 1994 Tumor spectrum analysis in p53-mutant mice. Curr Biol 4 1 7
45. HarveyMMcArthurMJMontgomeryCAJrButelJSBradleyA 1993 Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice. Nature genetics 5 225 229
46. SchmittCAMcCurrachMEde StanchinaEWallace-BrodeurRRLoweSW 1999 INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53. Genes Dev 13 2670 2677
47. EischenCMWeberJDRousselMFSherrCJClevelandJL 1999 Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev 13 2658 2669
48. HowesKARansomNPapermasterDSLasudryJGAlbertDM 1994 Apoptosis or retinoblastoma: alternative fates of photoreceptors expressing the HPV-16 E7 gene in the presence or absence of p53. Genes Dev 8 1300 1310
49. PanHGriepAE 1994 Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev 8 1285 1299
50. SymondsHKrallLRemingtonLSaenz-RoblesMLoweS 1994 p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78 703 711
51. JacksonELOliveKPTuvesonDABronsonRCrowleyD 2005 The differential effects of mutant p53 alleles on advanced murine lung cancer. Cancer Res 65 10280 10288
52. KempCJWheldonTBalmainA 1994 p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 8 66 69
53. AdamsJMHarrisAWPinkertCACorcoranLMAlexanderWS 1985 The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318 533 538
54. SchmittCAFridmanJSYangMBaranovEHoffmanRM 2002 Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 1 289 298
55. LevineBAbramsJ 2008 p53: The Janus of autophagy? Nature cell biology 10 637 639
56. CicaleseABonizziGPasiCEFarettaMRonzoniS 2009 The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells. Cell 138 1083 1095
57. LiuYElfSEMiyataYSashidaGHuangG 2009 p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4 37 48
58. BouhallierFAllioliNLavialFChalmelFPerrardMH 2010 Role of miR-34c microRNA in the late steps of spermatogenesis. RNA 16 720 731
59. LiuWMPangRTChiuPCWongBPLaoK 2012 Sperm-borne microRNA-34c is required for the first cleavage division in mouse. Proc Natl Acad Sci U S A 109 490 494
60. AgostiniMTucciPSteinertJRShalom-FeuersteinRRouleauM 2011 microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc Natl Acad Sci U S A 108 21099 21104
61. AgostiniMTucciPKillickRCandiESayanBS 2011 Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc Natl Acad Sci U S A 108 21093 21098
62. ZovoilisAAgbemenyahHYAgis-BalboaRCStillingRMEdbauerD 2011 microRNA-34c is a novel target to treat dementias. EMBO J 30 4299 4308
63. HaramatiSNavonIIsslerOEzra-NevoGGilS 2011 MicroRNA as repressors of stress-induced anxiety: the case of amygdalar miR-34. J Neurosci 31 14191 14203
64. LiuNLandrehMCaoKAbeMHendriksGJ 2012 The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482 519 523
65. LiuPJenkinsNACopelandNG 2003 A highly efficient recombineering-based method for generating conditional knockout mutations. Genome Res 13 476 484
66. RodriguezCIBuchholzFGallowayJSequerraRKasperJ 2000 High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet 25 139 140
67. SakaiKMiyazakiJ 1997 A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission. Biochem Biophys Res Commun 237 318 324
Štítky
Genetika Reprodukčná medicínaČlánok vyšiel v časopise
PLOS Genetics
2012 Číslo 7
- Je „freeze-all“ pro všechny? Odborníci na fertilitu diskutovali na virtuálním summitu
- Gynekologové a odborníci na reprodukční medicínu se sejdou na prvním virtuálním summitu
Najčítanejšie v tomto čísle
- Guidelines for Genome-Wide Association Studies
- GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers
- The Role of Rice HEI10 in the Formation of Meiotic Crossovers
- Identification of Chromatin-Associated Regulators of MSL Complex Targeting in Dosage Compensation